Sichuan Deebio Pharmaceutical Co., Ltd yemeye igenzura ryemewe rya GMP ryaturutse mu Buyapani PMDA kuva 8.25 kugeza 8.26 mu 2022. Itsinda ry’ubugenzuzi bwa GMP ryari rigizwe n’abagenzuzi babiri bayobowe n’inzobere z’inararibonye kandi bakora ubugenzuzi bw’iminsi ibiri.Impuguke zitsinda ryagenzuye zakoze igenzura ryimbitse rya sisitemu yo gucunga neza ubuziranenge bwa Deebio, sisitemu yo gucunga umusaruro, imikorere ikorerwa, imicungire ya laboratoire, ibikoresho bifasha ibikoresho, no gufata neza sisitemu rusange.

Binyuze mu igenzura, impuguke z’itsinda ry’ubugenzuzi zemeje kandi zemeza ko gahunda y’imicungire y’ubuziranenge ya GMP ya Deebio.Hanyuma, Deebio yatsinze neza icyemezo cya GMP cya PMDA yUbuyapani!

PMDA (Pharmaceuticals and Devices Devices Agency) ni ikigo cyabayapani gishinzwe gusuzuma tekiniki yibiyobyabwenge nibikoresho byubuvuzi.Irasa na FDA muri Amerika na NMPA mubushinwa.

Deebio yatsinze icyemezo cya EU-GMP n'Ubushinwa GMP.Gutsindira neza ibyemezo by’Ubuyapani PMDA byerekana intsinzi mu ntambwe ya Deebio ku isi!